The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so c3 tends to move with insulin so this right may be one of the things that explains why someone with type 2 diabetes who is hyperinsulinemic will on a particle for particle basis maybe even have a greater burden of the lipoprotein because the actual residence time of each of their particles both the LDL and LDL is longer than someone with lower insulin
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.